Factory 99% Tak-438 Powder CAS 1260141-27-2 Vonoprazan Fumarate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A317
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Tak-438
• CAS: 1260141-27-2
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	TAK-438
Appearance	White Powder
CAS NO.	1260141-27-2
Molecular Formula	C21h20fn3o6s
Storage	Keep in a cool, dry, dark location

 

TAK-438 is a novel, orally bioavailable small molecule inhibitor that targets a specific pathway or protein involved in cellular signaling or disease progression. It is under investigation for its potential therapeutic applications in various medical conditions.

 

 

1. Cancer Therapy: TAK-438 is being studied as a potential treatment for various types of cancer, including solid tumors and hematological malignancies, due to its ability to inhibit specific oncogenic pathways.
2. Inflammatory Diseases: The compound is also being explored for its potential to reduce inflammation and ameliorate symptoms in inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
3. Neurological Disorders: Preliminary studies suggest that TAK-438 may have therapeutic benefits in certain neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, by modulating neuronal signaling pathways.

1. Inhibition of Cellular Signaling Pathways: TAK-438 functions by inhibiting specific protein kinases or other enzymes involved in cellular signaling pathways that are implicated in disease progression.
2. Modulation of Gene Expression: In some instances, TAK-438 may also affect gene expression patterns, leading to changes in the production of proteins that contribute to disease development.
3. Enhancement of Therapeutic Effects: By targeting key pathways or proteins, TAK-438 may enhance the therapeutic effects of other medications or treatment modalities, leading to improved patient outcomes.